Price target for OptimizeRx (NASDAQ:OPRX) lowered to $14.00
OptimizeRx (NASDAQ:OPRX – Get Free Report) Royal Bank of Canada’s price target was cut from $17.00 to $14.00 in a research report published on Friday, Benzinga reports. The brokerage currently…